| Literature DB >> 35878204 |
Maria Michela Salvatore1,2, Marina DellaGreca1, Anna Andolfi1,3, Rosario Nicoletti4,5.
Abstract
Funicone-like compounds are a homogeneous group of polyketides that, so far, have only been reported as fungal secondary metabolites. In particular, species in the genus Talaromyces seem to be the most typical producers of this group of secondary metabolites. The molecular structure of funicone, the archetype of these products, is characterized by a γ-pyrone ring linked through a ketone group to a α-resorcylic acid nucleus. This review provides an update on the current knowledge on the chemistry of funicone-like compounds, with special emphasis on their classification, occurrence, and diverse biological activities. In addition, their potential relevance as mycotoxins is discussed.Entities:
Keywords: Penicillium; Talaromyces; fungal metabolites; mycotoxins; natural products; secondary metabolites
Mesh:
Substances:
Year: 2022 PMID: 35878204 PMCID: PMC9320429 DOI: 10.3390/toxins14070466
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 5.075
List of funicone-like compounds gathered from the literature.
| Code | Name | Formula | Nominal Mass (U) | Source |
|---|---|---|---|---|
|
| ||||
|
| Funicone | C19H18O8 | 374 | [ |
|
| Actofunicone | C21H22O9 | 418 | [ |
|
| Deoxyfunicone | C19H18O7 | 358 | [ |
|
| 9,14-Epoxy-11-deoxyfunicone | C19H18O8 | 374 | [ |
|
| 9 | C19H18O8 | 374 | [ |
|
| 9 | C19H18O8 | 374 | [ |
|
| 3- | C20H20O9 | 404 | [ |
|
| 6-Hydroxyl-deoxyfunicone | C19H18O8 | 374 | [ |
|
| Isofunicone | C19H18O8 | 374 | [ |
|
| 3- | C20H20O8 | 388 | [ |
|
| Rapicone | C17H16O7 | 332 | [ |
|
| Pinophilone A | C19H18O8 | 374 | [ |
|
| Pinophilone B | C19H18O8 | 374 | [ |
|
| ||||
|
| Penifupyrone | C19H18O8 | 374 | [ |
|
| ||||
|
| Vermistatin (=fijiensin) | C18H16O6 | 328 | [ |
|
| Acetoxydihydrovermistatin | C20H20O8 | 388 | [ |
|
| 6-Demethylvermistatin | C17H14O6 | 314 | [ |
|
| 14,15-Dihydrovermistatin | C18H18O6 | 330 | [ |
|
| 2″-epihydroxydihydrovermistatin | C18H18O7 | 346 | [ |
|
| Hydroxydihydrovermistatin | C18H18O7 | 346 | [ |
|
| Hydroxyvermistatin | C18H16O7 | 344 | [ |
|
| 5′- | C19H20O7 | 360 | [ |
|
| Methoxyvermistatin | C19H18O7 | 358 | [ |
|
| Neosarphenol A | C18H16O6 | 344 | [ |
|
| Penisimplicissin | C16H14O6 | 302 | [ |
|
| 6-Demethylpenisimplicissin | C15H12O6 | 288 | [ |
|
| 5′-Hydroxypenisimplicissin | C16H14O7 | 318 | [ |
|
| Pinophilone C | C17H16O6 | 316 | [ |
|
| Pinophilone D | C18H18O7 | 346 | [ |
|
| ||||
|
| Penicidone A | C18H17NO5 | 327 | [ |
|
| Penicidone B | C17H15NO5 | 313 | [ |
|
| Penicidone C | C19H19NO6 | 357 | [ |
|
| Penicidone D | C20H21NO7 | 387 | [ |
|
| Talarodone A | C20H23NO8 | 405 | [ |
Figure 1Structures of true funicones (1–13): funicone, actofunicone, deoxyfunicone, 9,14-epoxy-11-deoxyfunicone, 9R,14S-epoxy-11-deoxyfunicone, 9S,14R-epoxy-11-deoxyfunicone, 3-O-methyl-5,6-epoxyfunicone, 6-hydroxyl-deoxyfunicone, isofunicone, 3-O-methylfunicone, rapicone, pinophilone A, and pinophilone B.
Figure 2General procedures for synthesis of funicones.
Figure 3Structure of penifupyrone (14).
Figure 4Structures of compounds from the phthalide type (15–29): vermistatin, acetoxydihydrovermistatin, 6-demethylvermistatin, 14,15-dihydrovermistatin, 2″-epihydroxydihydrovermistatin, hydroxydihydrovermistatin, hydroxyvermistatin, 5′-O-methyldihydrovermistatin, methoxyvermistatin, neosarphenol A, penisimplicissin, 6-demethylpenisimplicissin, 5′-hydroxypenisimplicissin, pinophilone C, and pinophilone D.
Figure 5Structures of compounds from the pyridone type (30–34): penicidone A–D and talarodone A.
Fungal species/strains reported as producers of funicone-like compounds.
| Species | Source/Lifestyle/Substrate | Location | Compounds | Ref. |
|---|---|---|---|---|
| Endophytic in | Tucson |
| [ | |
| Endophytic in | Hong Kong (China) |
| [ | |
|
| Banana plant | Honduras |
| [ |
| Air in bakery | Nagoya (Japan) |
| [ | |
| endophytic in | Hainan (China) |
| [ | |
| Unknown | China |
| [ | |
|
Soft coral ( | Xuwen (China) |
| [ | |
| Sponge | Bali (Indonesia) |
| [ | |
| Sediment | Ross Sea |
| [ | |
| Unknown | Japan |
| [ | |
| Endophytic in | Maoer Mountain (China) |
| [ | |
| Unknown | Japan |
| [ | |
| Unknown | Japan |
| [ | |
| Ash | Mount Pinotubo (Philippines) |
| [ | |
|
|
| [ | ||
| Slovakia |
| [ | ||
| Soil | Hiroo (Japan) |
| [ | |
| Unknown | Japan |
| [ | |
| Endophytic in | Favignana Isle |
| [ | |
| Mangrove sediment | Xiamen (China) |
| [ | |
| Apple root | Sondrio Province (Italy) |
| [ | |
| Soil from rhizosphere of | Lecce Province |
| [ | |
| Soil from rhizosphere of | Techeng Isle (China) |
| [ | |
| Soil from rhizosphere of | Scafati (Italy) |
| [ | |
| Soil | Mohe (China) |
| [ | |
| Water | Berkeley Pit lake (USA) |
| [ | |
| Marine sediment | Zhejiang (China) |
| [ | |
| Salt pan | Australia |
| [ | |
| Seawater | Dongshan Isle (China) |
| [ | |
| Endophytic in | Hainan (China) |
| [ | |
| Endophytic in | Shanxi (China) |
| [ | |
| Endophytic in | Zijin Mountain (China) |
| [ | |
| Sponge ( | Xuwen County (China) |
| [ | |
| Soil | Thailand |
| [ | |
| Unknown | Pakistan |
| [ | |
Microbial species/strains reported as producers of funicone-like compounds in co-cultures.
| Species 1 | Species 2 | Source/Substrate | Location | Compounds | Ref. |
|---|---|---|---|---|---|
| mangrove mud | Yunxiao (China) |
| [ | ||
| rhizosphere of | Hainan (China) |
| [ | ||
| soil | Miyazaki (Japan) |
| [ | ||
| soil | Japan |
| [ |
Figure 6Proposed biosynthetic schemes of funicone-like compounds.
Main bioactivities of funicone-like compounds.
| Name (Code) | Bioactivity | Concentration | Bioassay | Ref. |
|---|---|---|---|---|
| Actofunicone ( | Reinforcement of miconazole | 3.7 µM | [ | |
| 6-Demethylpenisimplicissin ( | Enzyme inhibitory | 9.5 µM | α-glucosidase (IC50) | [ |
| Deoxyfunicone ( | Anticholesterol | 10 µM | Efflux from RAW264.7 | [ |
| Antiviral | 4.6 µM | HCV (IC50 on Huh-7.5.1) | [ | |
| Cytotoxic | 22.6 µM | KB (IC50) | [ | |
| Enzyme inhibitory | 24.3 µM | Protein tyrosine phosphate 1B (IC50) | [ | |
| 1.1–4.4 µM | HIV-1-integrase (IC50) | [ | ||
| Lipid inhibitory | 10 µM | Accumulation in HepG2 | [ | |
| Downregulation of FAS, ACC, HMGR | ||||
| Decrease in oxLDL in RAW264.7 | ||||
| NO inhibitory | 10.6 µM | LPS-stimulated BV2 (IC50) | [ | |
| PGE2 inhibitory | 32.3 µM | LPS-stimulated BV2 (IC50) | [ | |
| Reinforcement of miconazole | 1.6 µM | [ | ||
| 2″-epiHydroxydihydrovermistatin ( | Enzyme inhibitory | 8 µM | α-glucosidase (IC50) | [ |
| 9,14-Epoxy-11-deoxyfunicone ( | Antifungal | 0.53 µmol/disc |
| [ |
| 9 | Cytotoxic | 3.97 µM | H1975 (IC50) | [ |
| 9 | Cytotoxic | 3.73 µM | HL-60 (IC50) | [ |
| Funicone ( | Anticholesterol | 10 µM | Efflux from RAW264.7 | [ |
| Antifungal | 0.27 µmol/disc |
| [ | |
| Cytotoxic | 13.2 µM | KB (IC50) | [ | |
| Lipid inhibitory | 10 µM | Accumulation in HepG2 | [ | |
| Downregulation of FAS, ACC, HMGR | ||||
| Isofunicone ( | Pollen growth inhibitory | 8.02 mM | [ | |
| Hydroxyvermistatin ( | Anticholesterol | 10 µM | Efflux from RAW264.7 | [ |
| Upregulation of PPARγ, LXRα, ABCG1 | ||||
| Decrease scavenger receptors CD36, SR-1 | ||||
| Enzyme inhibitory | 20.3 µM | α-glucosidase (IC50) | [ | |
| Lipid inhibitory | 10 µM | Accumulation in HepG2 | [ | |
| Decrease in FAS, ACC, HMGR | ||||
| Decrease in oxLDL in RAW264.7 | ||||
| Methoxyvermistatin ( | Anticholesterol | 10 µM | Decrease scavenger receptors CD36, SR-1 | [ |
| Cytotoxic | 0.056 mM | KB (IC50) | [ | |
| Enzymatic inhibitory | 236 µM | α-glucosidase (IC50) | [ | |
| Lipid inhibitory | 10 µM | Decrease in oxLDL in RAW264.7 | [ | |
| 3- | Anticholesterol | 10 µM | Efflux from RAW264.7 | [ |
| Antifungal | 0.27 mM | [ | ||
| Antiviral | 5 µM | decreased mortality of MDBK infected by BoHV-1 | [ | |
| 6.2 µM | HCV (IC50 on Huh-7.5.1) | [ | ||
| Cytotoxic/ | 35.3 µM | KB (IC50) | [ | |
| 10 µM | MDBK (IC50) | [ | ||
| 63.8 µM | HCT116 (LD50) | [ | ||
| 0.16 mM | HEp-2; inhibition colony formation, decrease neutral red uptake, inhibition O2 consumption (IC50) | [ | ||
| 0.07 mM | HeLa (44%); promotion | [ | ||
| 0.21 mM | MCF-7; downregulates αvβ5 integrin, MMP-9 inhibitor, impairs microtubule assemblage, inhibitor of | [ | ||
| 0.21 mM | A375M (IC85, 48 h) | [ | ||
| 0.14 mM | NCI-H2452; decreases αvβ5 integrin, MMP-2, VEGF, ERK1/2; synergism with cisplatin | [ | ||
| Enzyme Inhibitory | 12.5 µM | DNA polymerase κ | [ | |
| 5 mM | DNA polymerase κ and η | [ | ||
| Insecticidal | 0.14 mM | [ | ||
| Lipid inhibitory | 10 µM | Accumulation in HepG2 | [ | |
| Decrease in FAS, ACC, HMGR | ||||
| Decrease in oxLDL in RAW264.7 | ||||
| Penicidone A ( | Cytotoxic | 60.1 µM | SW116 (IC50) | [ |
| Penicidone B ( | Cytotoxic | 54.2 µM | SW116 (IC50) | [ |
| Penicidone C ( | Cytotoxic | 80.8 µM | SW116 (IC50) | [ |
| Enzyme inhibitory | 51.9 µM | α-glucosidase (IC50) | [ | |
| Penifupyrone ( | Cytotoxic | 4.7 µM | KB (IC50) | [ |
| Penisimplicissin ( | Cytotoxic | −6.70 | CCRF-CEM (log10 GI50) | [ |
| Enzyme inhibitory | 0.66 mM | IL-1β (IC100) | [ | |
| Rapicone ( | Enzyme inhibitory | 5 mM | DNA polymerase κ | [ |
| Vermistatin ( | Antibacterial | 0.076 mM | [ | |
| Anticholesterol | 10 µM | Efflux from RAW264.7 | [ | |
| Decrease scavenger receptors CD36, SR-1 | ||||
| Cytotoxic | 0.28 mM | KB (IC50) | [ | |
| 33.9 µM | B16 (IC50) | [ | ||
| Enzyme inhibitory | 29.2 µM | α-glucosidase (IC50) | [ | |
| 107.1 µM | α-glucosidase (IC50) | [ | ||
| Insecticidal | 0.46 mM | [ | ||
| Lipid inhibitory | 10 µM | accumulation in HepG2 | [ | |
| Decrease in FAS, ACC, HMGR | ||||
| Decrease in oxLDL in RAW264.7 | ||||
| NO inhibitory | 52.7 µM | LPS-stimulated BV2 (IC50) | [ | |
| Phytotoxic | 3.1–6.1 mM | Banana leaves | [ | |
| Reinforcement of miconazole | 2.1 µM | [ |